BioSpace News Archive

Aesthetic Medical International Holdings Group Limited, a leading provider of aesthetic medical services in China, and Forbes China have jointly released the Chinese Aesthetic Treatment Industry White Paper 2020, the first white paper on the aesthetic treatment industry in China.

Theravance Biopharma, Inc., a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will report its fourth quarter and full year 2020 financial results and provide a business update after market close on Tuesday, February 23, 2021.

Applied UV, Inc. announced it has closed on the acquisition by its wholly-owned subsidiary, SteriLumen, Inc., of substantially all of the assets of Akida Holdings LLC, including all of the rights to manufacture and sell the Airocide® System of patented, air disinfection and purification technologies, for 1.375 million common shares of Applied UV stock and $901,274.96 in cash.

Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence, focused on fulfilling the promise of precision medicine, announced today that David D. Halbert , Chairman and Chief Executive Officer, Brian J. Brille , Vice Chairman, David Spetzler , MS, MBA, Ph.D., President and Chief Scientific Officer will host a fireside chat at the BTIG Virtual MedTech Conference 2021

Acasti Pharma Inc. announced its operating and financial results for the third quarter of fiscal 2021 ended December 31, 2020.

Triastek, Inc. (“Triastek”), a pharmaceutical company specializing in 3D printing of drug products, announced today that the United States Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) 505(b)(2) application for its first 3D printed drug product – T19

Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that its early liver cancer screening research results were cited by the “Chinese Anti-Cancer Association Guidelines for Patients with Primary Liver Cancer”

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference. Management will participate in a virtual fireside chat at the conference on Wednesday, February 17th at 10:00 a.m. Eastern Time.

AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Brands”) is pleased to announce the appointment of Dr. Roscoe Moore DVM, MPH, PhD, Former Assistant United States Surgeon General to the Scientific Advisory Board for AREV Nanotec Brands Inc, to provide strategic planning for AREV drug discovery planning, as a Senior Scientific Advisor.

Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is using its platform to genetically engineer red blood cells into medicines, called Red Cell Therapeutics™, for the treatment of cancer and autoimmune diseases, today announced plans to report fourth quarter and full year 2020 financial results on Tuesday, February 23, 2021, before market open.